Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
33%(2 trials)

Phase Distribution

Ph not_applicable
7
78%
Ph phase_3
2
22%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
2(22.2%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(6)
Other(3)

Detailed Status

Completed6
unknown3

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (22.2%)
N/A7 (77.8%)

Trials by Status

unknown333%
completed667%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DEVICE
Total Trials
9